609 related articles for article (PubMed ID: 26979456)
21. Zwitterionic polymer on silicone implants inhibits the bacteria-driven pathogenic mechanism and progress of breast implant-associated anaplastic large cell lymphoma.
Kim J; Kang S; Choi MH; Park S; Nam SH; Park JU; Lee Y
Acta Biomater; 2023 Nov; 171():378-391. PubMed ID: 37683967
[TBL] [Abstract][Full Text] [Related]
22. Breast implant-associated anaplastic large cell lymphoma: review of a distinct clinicopathologic entity.
Xu J; Wei S
Arch Pathol Lab Med; 2014 Jun; 138(6):842-6. PubMed ID: 24878027
[TBL] [Abstract][Full Text] [Related]
23. Spontaneous Regression and Resolution of Breast Implant-Associated Anaplastic Large Cell Lymphoma: Implications for Research, Diagnosis and Clinical Management.
Fleming D; Stone J; Tansley P
Aesthetic Plast Surg; 2018 Jun; 42(3):672-678. PubMed ID: 29445921
[TBL] [Abstract][Full Text] [Related]
24. CD30+ T Cells in Late Seroma May Not Be Diagnostic of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Kadin ME; Morgan J; Xu H; Glicksman CA
Aesthet Surg J; 2017 Jul; 37(7):771-775. PubMed ID: 28402493
[TBL] [Abstract][Full Text] [Related]
25. [Thirty-six (36) French cases of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL): What do we know about their prosthetic histories, and what conclusions may be drawn?].
Ruffenach L; Bruant-Rodier C; Goldammer F; Ramelli E; Bodin F; Dissaux C
Ann Chir Plast Esthet; 2019 Aug; 64(4):285-292. PubMed ID: 31331683
[TBL] [Abstract][Full Text] [Related]
26. Chromosome 20 loss is characteristic of breast implant-associated anaplastic large cell lymphoma.
Los-de Vries GT; de Boer M; van Dijk E; Stathi P; Hijmering NJ; Roemer MGM; Mendeville M; Miedema DM; de Boer JP; Rakhorst HA; van Leeuwen FE; van der Hulst RRWJ; Ylstra B; de Jong D
Blood; 2020 Dec; 136(25):2927-2932. PubMed ID: 33331925
[TBL] [Abstract][Full Text] [Related]
27. Flow cytometry of ALK-negative anaplastic large cell lymphoma of breast implant-associated effusion and capsular tissue.
Wu D; Allen CT; Fromm JR
Cytometry B Clin Cytom; 2015 Jan; 88(1):58-63. PubMed ID: 25044944
[TBL] [Abstract][Full Text] [Related]
28. Validation of a CD30 Enzyme-Linked Immunosorbant Assay for the Rapid Detection of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Hanson SE; Hassid VJ; Branch-Brooks C; Liu J; Kadin ME; Miranda R; Butler CE; Clemens MW
Aesthet Surg J; 2020 Jan; 40(2):149-153. PubMed ID: 30789639
[TBL] [Abstract][Full Text] [Related]
29. Cytological features of breast implant-associated anaplastic large cell lymphoma in pleural effusion.
D'Alessandris N; Lucatelli P; Tripodi D; Amabile MI; Ascoli V
Diagn Cytopathol; 2019 Nov; 47(11):1213-1217. PubMed ID: 31348611
[TBL] [Abstract][Full Text] [Related]
30. Current Risk Estimate of Breast Implant-Associated Anaplastic Large Cell Lymphoma in Textured Breast Implants.
Collett DJ; Rakhorst H; Lennox P; Magnusson M; Cooter R; Deva AK
Plast Reconstr Surg; 2019 Mar; 143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):30S-40S. PubMed ID: 30817554
[TBL] [Abstract][Full Text] [Related]
31. Breast Reconstruction Following Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Lamaris GA; Butler CE; Deva AK; Miranda RN; Hunt KK; Connell T; Lipa JE; Clemens MW
Plast Reconstr Surg; 2019 Mar; 143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):51S-58S. PubMed ID: 30817556
[TBL] [Abstract][Full Text] [Related]
32. Breast Implant-Associated Anaplastic Large Cell Lymphoma: Defining Future Research Priorities.
DeCoster RC; Lynch EB; Bonaroti AR; Miranda RN; Hunt KK; Clemens MW
Clin Plast Surg; 2021 Jan; 48(1):33-43. PubMed ID: 33220903
[TBL] [Abstract][Full Text] [Related]
33. Implications of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) for Breast Cancer Reconstruction: An Update for Surgical Oncologists.
O'Neill AC; Zhong T; Hofer SOP
Ann Surg Oncol; 2017 Oct; 24(11):3174-3179. PubMed ID: 28762113
[TBL] [Abstract][Full Text] [Related]
34. Breast implant-associated anaplastic large cell lymphoma, an under-recognised entity.
Gunawardana RT; Dessauvagie BF; Taylor DB
J Med Imaging Radiat Oncol; 2019 Oct; 63(5):630-638. PubMed ID: 31173460
[TBL] [Abstract][Full Text] [Related]
35. Breast implant-associated anaplastic large cell lymphoma: A comprehensive review.
Marra A; Viale G; Pileri SA; Pravettoni G; Viale G; De Lorenzi F; Nolè F; Veronesi P; Curigliano G
Cancer Treat Rev; 2020 Mar; 84():101963. PubMed ID: 31958739
[TBL] [Abstract][Full Text] [Related]
36. Best Practices Guideline for the Pathologic Diagnosis of Breast Implant-Associated Anaplastic Large-Cell Lymphoma.
Jaffe ES; Ashar BS; Clemens MW; Feldman AL; Gaulard P; Miranda RN; Sohani AR; Stenzel T; Yoon SW
J Clin Oncol; 2020 Apr; 38(10):1102-1111. PubMed ID: 32045544
[TBL] [Abstract][Full Text] [Related]
37. Insights into the Microbiome of Breast Implants and Periprosthetic Tissue in Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Walker JN; Hanson BM; Pinkner CL; Simar SR; Pinkner JS; Parikh R; Clemens MW; Hultgren SJ; Myckatyn TM
Sci Rep; 2019 Jul; 9(1):10393. PubMed ID: 31316085
[TBL] [Abstract][Full Text] [Related]
38. Is Breast Implant-Associated Anaplastic Large Cell Lymphoma Better Classified as a Lymphoproliferative Disorder and How Surgeons Reduce Risk?
Lukavsky RJ; Couto RA; Adams WP
Clin Plast Surg; 2021 Jan; 48(1):71-77. PubMed ID: 33220906
[TBL] [Abstract][Full Text] [Related]
39. Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Systematic Review.
Leberfinger AN; Behar BJ; Williams NC; Rakszawski KL; Potochny JD; Mackay DR; Ravnic DJ
JAMA Surg; 2017 Dec; 152(12):1161-1168. PubMed ID: 29049466
[TBL] [Abstract][Full Text] [Related]
40. Epidemiological Profile in Portugal of Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Cross-Sectional Study.
Cunha A; Horta R; Barreiro D
Acta Med Port; 2021 Aug; 34(9):572-579. PubMed ID: 33512315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]